APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurokinin Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurokinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025184 pages

Choose your research edition.

Industry ResearchNeurokinin Receptor Antagonists Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurokinin Receptor Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Neurokinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurokinin Receptor Antagonists Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurokinin Receptor Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Neurokinin Receptor Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurokinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurokinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurokinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurokinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurokinin Receptor Antagonists include Merck, Bayer, Zoetis, TerSera Therapeutics, Heron Therapeutics, Helsinn Healthcare and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurokinin Receptor Antagonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurokinin Receptor Antagonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurokinin Receptor Antagonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurokinin Receptor Antagonists market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurokinin Receptor Antagonists Segment by Company

Merck

Bayer

Zoetis

TerSera Therapeutics

Heron Therapeutics

Helsinn Healthcare

Astellas Pharma

Neurokinin Receptor Antagonists Segment by Type

NK-1 Receptor Antagonists

NK-3 Receptor Antagonists

Others

Neurokinin Receptor Antagonists Segment by Application

Vasomotor Symptoms

Nausea and Vomiting

Others

Neurokinin Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurokinin Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurokinin Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurokinin Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurokinin Receptor Antagonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurokinin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurokinin Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurokinin Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurokinin Receptor Antagonists Industry Trends Table 2. Neurokinin Receptor Antagonists Industry Drivers Table 3. Neurokinin Receptor Antagonists Industry Opportunities and Challenges Table 4. Neurokinin Receptor Antagonists Industry Restraints Table 5. Global Neurokinin Receptor Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurokinin Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurokinin Receptor Antagonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers Table 9. Global Neurokinin Receptor Antagonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Neurokinin Receptor Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurokinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurokinin Receptor Antagonists Manufacturers, Product Type & Application Table 13. Global Neurokinin Receptor Antagonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurokinin Receptor Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of NK-1 Receptor Antagonists Table 17. Major Manufacturers of NK-3 Receptor Antagonists Table 18. Major Manufacturers of Others Table 19. Global Neurokinin Receptor Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 21. Global Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 22. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2026) Table 23. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2027-2032) Table 24. Global Neurokinin Receptor Antagonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (K Units) Table 26. Global Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (K Units) Table 27. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2026) Table 28. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Vasomotor Symptoms Table 30. Major Manufacturers of Nausea and Vomiting Table 31. Major Manufacturers of Others Table 32. Global Neurokinin Receptor Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 34. Global Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 35. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2026) Table 36. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2027-2032) Table 37. Global Neurokinin Receptor Antagonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (K Units) Table 39. Global Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (K Units) Table 40. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2026) Table 41. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2027-2032) Table 42. Global Neurokinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Neurokinin Receptor Antagonists Sales by Region (2021-2026) & (K Units) Table 44. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2021-2026) Table 45. Global Neurokinin Receptor Antagonists Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Neurokinin Receptor Antagonists Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 49. North America Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 50. Europe Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 52. Europe Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 59. Global Neurokinin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Neurokinin Receptor Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Neurokinin Receptor Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2021-2026) Table 63. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2027-2032) Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck Neurokinin Receptor Antagonists Product Portfolio Table 68. Merck Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bayer Neurokinin Receptor Antagonists Product Portfolio Table 73. Bayer Recent Development Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Zoetis Neurokinin Receptor Antagonists Product Portfolio Table 78. Zoetis Recent Development Table 79. TerSera Therapeutics Company Information Table 80. TerSera Therapeutics Business Overview Table 81. TerSera Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio Table 83. TerSera Therapeutics Recent Development Table 84. Heron Therapeutics Company Information Table 85. Heron Therapeutics Business Overview Table 86. Heron Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio Table 88. Heron Therapeutics Recent Development Table 89. Helsinn Healthcare Company Information Table 90. Helsinn Healthcare Business Overview Table 91. Helsinn Healthcare Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio Table 93. Helsinn Healthcare Recent Development Table 94. Astellas Pharma Company Information Table 95. Astellas Pharma Business Overview Table 96. Astellas Pharma Neurokinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio Table 98. Astellas Pharma Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Neurokinin Receptor Antagonists Distributors List Table 102. Neurokinin Receptor Antagonists Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Neurokinin Receptor Antagonists Product Image Figure 2. Global Neurokinin Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurokinin Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurokinin Receptor Antagonists Sales (2021-2032) & (K Units) Figure 5. Global Neurokinin Receptor Antagonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurokinin Receptor Antagonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. NK-1 Receptor Antagonists Image Figure 9. NK-3 Receptor Antagonists Image Figure 10. Others Image Figure 11. Global Neurokinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Neurokinin Receptor Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2032) Figure 14. Global Neurokinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Neurokinin Receptor Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2032) Figure 17. Vasomotor Symptoms Image Figure 18. Nausea and Vomiting Image Figure 19. Others Image Figure 20. Global Neurokinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Neurokinin Receptor Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2032) Figure 23. Global Neurokinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Neurokinin Receptor Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2032) Figure 26. North America Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Neurokinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 28. U.S. Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Neurokinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 33. Germany Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Neurokinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 40. China Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 48. Brazil Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Neurokinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Neurokinin Receptor Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Neurokinin Receptor Antagonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 59. North America Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 61. Europe Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Neurokinin Receptor Antagonists Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Neurokinin Receptor Antagonists Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • NK-1 Receptor Antagonists
  • NK-3 Receptor Antagonists
  • Others
Applications
  • Vasomotor Symptoms
  • Nausea and Vomiting
  • Others
Companies covered
  • Merck
  • Bayer
  • Zoetis
  • TerSera Therapeutics
  • Heron Therapeutics
  • Helsinn Healthcare
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurokinin Receptor Antagonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurokinin Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurokinin Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurokinin Receptor Antagonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurokinin Receptor Antagonists Market Dynamics
  1. 2.1 Neurokinin Receptor Antagonists Industry Trends
  2. 2.2 Neurokinin Receptor Antagonists Industry Drivers
  3. 2.3 Neurokinin Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 Neurokinin Receptor Antagonists Industry Restraints
3 Neurokinin Receptor Antagonists Market by Manufacturers
  1. 3.1 Global Neurokinin Receptor Antagonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurokinin Receptor Antagonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurokinin Receptor Antagonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurokinin Receptor Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurokinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurokinin Receptor Antagonists Manufacturers, Product Type & Application
  7. 3.7 Global Neurokinin Receptor Antagonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurokinin Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurokinin Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurokinin Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 Neurokinin Receptor Antagonists Market by Type
  1. 4.1 Neurokinin Receptor Antagonists Type Introduction
  2. 4.1.1 NK-1 Receptor Antagonists
  3. 4.1.2 NK-3 Receptor Antagonists
  4. 4.1.3 Others
  5. 4.2 Global Neurokinin Receptor Antagonists Sales by Type
  6. 4.2.1 Global Neurokinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  8. 4.2.3 Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2032)
  9. 4.3 Global Neurokinin Receptor Antagonists Revenue by Type
  10. 4.3.1 Global Neurokinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  12. 4.3.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2032)
5 Neurokinin Receptor Antagonists Market by Application
  1. 5.1 Neurokinin Receptor Antagonists Application Introduction
  2. 5.1.1 Vasomotor Symptoms
  3. 5.1.2 Nausea and Vomiting
  4. 5.1.3 Others
  5. 5.2 Global Neurokinin Receptor Antagonists Sales by Application
  6. 5.2.1 Global Neurokinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 5.2.3 Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2032)
  9. 5.3 Global Neurokinin Receptor Antagonists Revenue by Application
  10. 5.3.1 Global Neurokinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  12. 5.3.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2032)
6 Global Neurokinin Receptor Antagonists Sales by Region
  1. 6.1 Global Neurokinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurokinin Receptor Antagonists Sales by Region (2021-2032)
  3. 6.2.1 Global Neurokinin Receptor Antagonists Sales by Region (2021-2026)
  4. 6.2.2 Global Neurokinin Receptor Antagonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurokinin Receptor Antagonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurokinin Receptor Antagonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurokinin Receptor Antagonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurokinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurokinin Receptor Antagonists Revenue by Region
  1. 7.1 Global Neurokinin Receptor Antagonists Revenue by Region
  2. 7.1.1 Global Neurokinin Receptor Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurokinin Receptor Antagonists Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurokinin Receptor Antagonists Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurokinin Receptor Antagonists Revenue (2021-2032)
  8. 7.2.2 North America Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurokinin Receptor Antagonists Revenue (2021-2032)
  11. 7.3.2 Europe Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurokinin Receptor Antagonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurokinin Receptor Antagonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurokinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Neurokinin Receptor Antagonists Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Neurokinin Receptor Antagonists Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Neurokinin Receptor Antagonists Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 TerSera Therapeutics
  20. 8.4.1 TerSera Therapeutics Company Information
  21. 8.4.2 TerSera Therapeutics Business Overview
  22. 8.4.3 TerSera Therapeutics Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio
  24. 8.4.5 TerSera Therapeutics Recent Developments
  25. 8.5 Heron Therapeutics
  26. 8.5.1 Heron Therapeutics Company Information
  27. 8.5.2 Heron Therapeutics Business Overview
  28. 8.5.3 Heron Therapeutics Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio
  30. 8.5.5 Heron Therapeutics Recent Developments
  31. 8.6 Helsinn Healthcare
  32. 8.6.1 Helsinn Healthcare Company Information
  33. 8.6.2 Helsinn Healthcare Business Overview
  34. 8.6.3 Helsinn Healthcare Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio
  36. 8.6.5 Helsinn Healthcare Recent Developments
  37. 8.7 Astellas Pharma
  38. 8.7.1 Astellas Pharma Company Information
  39. 8.7.2 Astellas Pharma Business Overview
  40. 8.7.3 Astellas Pharma Neurokinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio
  42. 8.7.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurokinin Receptor Antagonists Value Chain Analysis
  2. 9.1.1 Neurokinin Receptor Antagonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurokinin Receptor Antagonists Production Mode & Process
  6. 9.2 Neurokinin Receptor Antagonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurokinin Receptor Antagonists Distributors
  9. 9.2.3 Neurokinin Receptor Antagonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst